These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31584773)

  • 1. Study of the allelic variants CYP2C9*2 and CYP2C9*3 in samples of the Peruvian mestizo population.
    Alvarado ÁT; Muñoz AM; Loja B; Miyasato JM; García JA; Cerro RA; Quiñones LA; Varela NM
    Biomedica; 2019 Sep; 39(3):601-610. PubMed ID: 31584773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population.
    Céspedes-Garro C; Rodrigues-Soares F; Jiménez-Arce G; Naranjo MG; Tarazona-Santos E; Fariñas H; Barrantes R; Llerena A;
    Rev Biol Trop; 2016 Sep; 64(3):1067-76. PubMed ID: 29461783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9 allelic variants: ethnic distribution and functional significance.
    Xie HG; Prasad HC; Kim RB; Stein CM
    Adv Drug Deliv Rev; 2002 Nov; 54(10):1257-70. PubMed ID: 12406644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.
    Giri AK; Khan NM; Grover S; Kaur I; Basu A; Tandon N; Scaria V; ; ; Kukreti R; Brahmachari SK; Bharadwaj D
    Pharmacogenomics; 2014 Jul; 15(10):1337-54. PubMed ID: 25155935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.
    Saldaña-Cruz AM; León-Moreno LC; Sánchez-Corona J; Santiago DA; Mendoza-Carrera F; Castro-Martínez XH; García-Zapién AG; Morán-Moguel MC; Flores-Martínez SE
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):702-709. PubMed ID: 27617498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.
    Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ
    Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.
    McGrane IR; Loveland JG
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):395-9. PubMed ID: 26871369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations.
    Flores-Gutiérrez S; Rodríguez-Larralde Á; Vívenes de Lugo M; Castro de Guerra D
    Ann Hum Biol; 2017 Mar; 44(2):191-198. PubMed ID: 27230833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
    Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.
    Villegas-Torres B; Sánchez-Girón F; Jaramillo-Villafuerte K; Soberón X; Gonzalez-Covarrubias V
    Gene; 2015 Mar; 558(2):235-40. PubMed ID: 25560189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2C9 allelic variants and frequencies in a pediatric sickle cell disease cohort: implications for NSAIDs pharmacotherapy.
    Jaja C; Patel N; Scott SA; Gibson R; Kutlar A
    Clin Transl Sci; 2014 Oct; 7(5):396-401. PubMed ID: 24889181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations.
    Yang JQ; Morin S; Verstuyft C; Fan LA; Zhang Y; Xu CD; Barbu V; Funck-Brentano C; Jaillon P; Becquemont L
    Fundam Clin Pharmacol; 2003 Jun; 17(3):373-6. PubMed ID: 12803577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.
    Yasar U; Aklillu E; Canaparo R; Sandberg M; Sayi J; Roh HK; Wennerholm A
    Eur J Clin Pharmacol; 2002 Nov; 58(8):555-8. PubMed ID: 12451434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele frequency distribution of CYP2C9 2 and CYP2C9 3 polymorphisms in six Mexican populations.
    Castelán-Martínez OD; Hoyo-Vadillo C; Sandoval-García E; Sandoval-Ramírez L; González-Ibarra M; Solano-Solano G; Gómez-Díaz RA; Parra EJ; Cruz M; Valladares-Salgado A
    Gene; 2013 Jul; 523(2):167-72. PubMed ID: 23587916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo characterization of 13 CYP2C9 allelic variants found in Chinese Han population.
    Hu GX; Pan PP; Wang ZS; Yang LP; Dai DP; Wang SH; Zhu GH; Qiu XJ; Xu T; Luo J; Lian QQ; Ge RS; Cai JP
    Drug Metab Dispos; 2015 Apr; 43(4):561-9. PubMed ID: 25614704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
    Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
    Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards.
    Dorado P; Sosa-Macias MG; Peñas-Lledó EM; Alanis-Bañuelos RE; Wong ML; Licinio J; Lares-Asseff I; Llerena A
    Pharmacogenomics J; 2011 Apr; 11(2):108-12. PubMed ID: 20458343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans.
    Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Sosa-Macías M; Terán E; López-López M; Rodeiro I; Moya GE; Calzadilla LR; Ramírez-Roa R; Grazina M; Estévez-Carrizo FE; Barrantes R; LLerena A;
    Clin Pharmacol Ther; 2020 Jan; 107(1):257-268. PubMed ID: 31376146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
    Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
    Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.